Join over 250 leaders, experts and scientists to discuss strategies to harness the immune system for the development of innovative therapeutics
Featuring over 40 presentations, the event brings together leading pharma, biotech and academic organisations designing innovative strategies and technologies for more effective cancer immunotherapy development
Over 200 attendees representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic and healthcare institutions developing immuno-oncology therapies and tools
Over 40 presentations and case studies focussed on the latest innovations in Immuno-Oncology therapy development, patient stratification and clinical research
The 2021 Series again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook.
The following were confirmed speakers for the 2019 series.
Book now to take advantage of early registration rates.
Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of Series features and make the most of participation in a range of on-site experiences.